ⅢB期宫颈癌阴道下三分之一受累者预后更差
伴LTI者2年及5年总生存率和无进展生存率均显著低于不伴LTI者,多因素分析显示LTI与总生存率相关。
要点
- ⅢB期宫颈癌伴LTI者2年OS为68.9%、5年OS为38.8%,低于不伴LTI者的79.9%和58.9%。
- 伴LTI者2年PFS为45.9%、5年PFS为37.0%,低于不伴LTI者的63.3%和53.1%。
- 多因素分析显示LTI是ⅢB期宫颈癌总生存率的独立影响因素。
核心结论
- ⅢB期宫颈癌伴阴道下三分之一受累者的预后显著差于不伴LTI者。
研究设计与样本
- 其中74例伴LTI,548例不伴LTI,采用Cox回归模型和卡方或Fisher精确检验分析。
主要发现
- 不伴LTI组2年和5年总生存率分别为79.9%和58.9%,伴LTI组分别为68.9%和38.8%(P=0.001)。
- 不伴LTI组2年和5年无进展生存率分别为63.3%和53.1%,伴LTI组分别为45.9%和37.0%(P=0.002)。
- 多因素Cox回归显示组织学类型、总治疗时间、肾积水和治疗方案是影响PFS率的显著因素。
- 总生存率与组织学类型、肾积水、治疗方案和LTI相关。
临床怎么用
- 对ⅢB期宫颈癌患者应评估是否存在阴道下三分之一受累,以辅助预后判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Previous studies have evaluated the prognostic factors of patients with stage IIIB cervical cancer. However, there was only one study evaluating the relationship between LTI (lower third of vaginal invasion) and the prognosis of the patients with stage IIIB cervical cancer. Our research aimed to assess different therapeutic outcomes of the stage IIIB CCP (cervical cancer patients) with or without LTI. METHODS: From December 2007 to December 2014, patients with FIGO (International Federation of Gynecology and Obstetrics, 2009) stage IIIB cervical cancer admitted and treated in Zhejiang Cancer Hospital were enrolled and evaluated in this retrospective research. Different clinicopathological variables and treatment outcomes were analyzed by using multivariate and univariate Cox regression models and chi-square or Fisher's exact test. RESULTS: The number of enrolled patients was 622, among which 74 cases were with LTI and 548 without. The two- and five-year OS (overall survival) rates in non-LTI group were 79.9% and 58.9%, and the OS rates in LTI group were 68.9% and 38.8%, respectively (P = 0.001). The two- and five-year PFS (progression-free survival) rates in non-LTI group were 63.3% and 53.1%, and the PFS rates in LTI group were 45.9% and 37.0% respectively (P = 0.002). Multivariate Cox regression analysis indicated that histological type, total treatment time, hydronephrosis, and treatment protocol were factors significantly affecting the PFS rates in stage IIIB CCP, and OS rates were associated with histological type, hydronephrosis, treatment protocol, and LTI. CONCLUSIONS: Our study showed that stage IIIB CCP with LTI had worse prognosis than those without LTI.
引用
- Fang C, Zhang P, Yu A, et al. Different prognosis of stage IIIB cervical cancer patients with lower third of vaginal invasion and those without. Gynecol Oncol. 2021. PMID: 33858676. doi:10.1016/j.ygyno.2021.04.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。